Bocunebart

Bocunebart is a humanized monoclonal antibody targeting human adenylate cyclase-activating polypeptide (ADCYAP1) . Bocunebart exerts anti-inflammatory activity by specifically binding to ADCYAP1 and inhibiting related inflammatory signaling pathways. Bocunebart is promising for research of inflammation-related diseases[1].

Product Specifications

CAS Number

[2984605-64-1]

UNSPSC

12352203

Target

Adenylate Cyclase

Related Pathways

GPCR/G Protein

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Smiles

[Bocunebart]

References & Citations

[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

Shipping Conditions

Room temperature

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-06531G 0.1 mL

Rabbit Polyclonal LMX1b Antibody [DyLight 488]

Ask

View Details

RC212863L2V 200 µL

HDAC5 (NM_005474) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details

MAB2805-100 100 µg

Mouse MFG-E8 MAb (Clone 340614)

Ask

View Details

bs-8068R-PerCP-Cy5.5 100 µL

SRRM3 Polyclonal Antibody, PerCP-Cy5.5 Conjugated

Ask

View Details

MBS1404123-01 0.02 mg (E-Coli)

Recombinant Bacillus cereus UPF0738 protein BC_1197 (BC_1197)

Ask

View Details

MBS1404123-02 0.1 mg (E-Coli)

Recombinant Bacillus cereus UPF0738 protein BC_1197 (BC_1197)

Ask

View Details